Global Anxiety Disorder and Depression Treatments Market Size was valued nearly USD 15.2 billion by 2016 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 3.01% during the forecast period that is 2017-2025. North America dominated the global anxiety disorder & depression treatments market in 2017 and is expected to retain market dominance throughout the forecast period.  

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global anxiety disorder and depression treatments market market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global anxiety disorder and depression treatments market market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Market Dynamics

Depression and anxiety are common forms of psychiatric disorders which are prevalent among a large chunk of the population. Major depression of depressive disorders is a diagnosable condition that is classified as a mood disorder and its effects can be a long-term issue with symptoms such as reduced energy, overwhelming sadness, loss of appetite, and low interest on things. Depression, if left untreated can result in severe health complications and is considered to be life-threatening. Types of depression include persistent depressive disorder, bipolar disorder, seasonal depression, postpartum depression and psychotic depression among others.

Global anxiety disorder and depression treatments market is majorly driven by the rising number of people with severe anxiety and depression at the global level. According to the World Health Organization, approximately 300 million people across the globe suffer from depression. Further, according to our research experts, in 2017, more than 10 million residents in the U.S. experienced incidences of depression which resulted in severe impairment. Further, according to the Anxiety & Depression Association of America, more than 40 million residents in the U.S. aged 18 and above, which is equivalent to 18.1% of the overall population of the country suffer from anxiety disorders each year. These factors have paved the way for anxiety disorder and depression treatments market.

Segment Analysis

Product Insights: Based on product type, anti-depressant drugs accounted for the major share of global anxiety disorder & depression treatments market in 2017, the growth of which is majorly attributed to the influx of advanced techniques to counter mental illness coupled the rising use of an antidepressant in depressive disorder treatment. Moreover, antidepressant drugs are widely used in several anxiety disorders such as traumatic stress, panic disorder, phobia, and others.

Disorder Insights: On the basis of disorder types, Major Depressive Disorder (MDD) is anticipated to hold prime share in the global anxiety disorder and depression treatments market, primarily owing to the rising incidences of this disorder, making it a common type disorder. According to the National Institute of National Health, more than 16.2 million adults in the U.S. suffered from at least one type of MDD in 2016. Therefore, rising cases of MDD would lead to nudge the global anxiety disorder & depression treatments market in the coming decade.

Regional Analysis

The global anxiety disorder and depression treatments market is divided into regions that are North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America dominated the global anxiety disorder & depression treatments market in 2017 and is expected to retain market dominance throughout the forecast period. This is primarily owing to the huge chunk of the population in the U.S. are currently suffering from anxiety disorders. According to the Anxiety and Depression Association of America, 40 million adults in the U.S. are affected every year whereby making it a most common type disorder. The treatment for this disorder in the U.S. such as several antidepressant drugs is readily available on prescription.

Global Anxiety Disorder and Depression Treatments Market Size, Share Analysis By Region 2017

The Asia Pacific, however, is gaining rapid prominence in the global anxiety disorder & depression treatments market on account of rising working population and busier lifestyles of the younger populace. India and China are the frontrunners to the growth of this industry in the Asia Pacific. According to the Associated Chambers of Commerce and Industry of India, approximately 42% of the employees working in the Indian corporate sector were found to be suffering from depression in 2015, which marked an approximate of 40% growth over the last 8 years. These are some of the factors resulting in a high demand for anxiety disorder & depression treatments market in the country.

Global Anxiety Disorder and Depression Treatments Market Study Objective

1. To forecast the market size of anxiety disorder and depression treatments market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of anxiety disorder and depression treatments market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of anxiety disorder and depression treatments market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of anxiety disorder and depression treatments market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the anxiety disorder and depression treatments market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Competitive Landscape

Some of the key players operating in the global anxiety disorder & depression treatments market include GlaxoSmithKline Plc, AstraZeneca Plc, El Lily & Company, Johnson & Johnson Inc., and H Lundbeck A/S among others. Mergers and acquisition, product development and launch, investments are some of the key strategies adopted by the numerous companies in the global anxiety disorder & depression treatments market to grab a strong foothold. For instance, in May 2018, H Lundbeck announced the approval made on the supplemental new drug for Trintellix by U.S. Food and Drug Administration (FDA) to be used for the patients suffering from the major depressive disorder (MDD), majorly owing to its positive effect on processing speed.

Global Anxiety Disorder and Depression Treatments Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.